EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

[Translated article] Cost-effectiveness of immune checkpoint inhibitors for non-small cell lung cancer in a third level hospital

Ana Álvarez-Yuste, María Pérez-Abánades, Ramón Colomer-Bosch, Irene Cuadrado-Berrocal, Jacobo Rogado-Revuelta, Tomás Gallego-Aranda, Ainhoa Aranguren-Oyarzábal

Farmacia Hospitalaria · 2026-07

DOI: 10.1016/j.farma.2026.04.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Farmacia Hospitalaria, 2026-07. Verfasst von Ana Álvarez-Yuste und 6 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Farmacia Hospitalaria, Hospital Universitario de la Princesa, Madrid, Spain. Electronic address: aalvarezy@salud.madrid.org. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Análisis coste-efectividadCost-effectiveness analysisCáncer de pulmón no microcíticoImmune checkpoint inhibitorsInhibidores de punto de control inmunitarioNon-small cell lung cancer

Autor:innen und Institutionen

  • Servicio de Farmacia Hospitalaria, Hospital Universitario de la Princesa, Madrid, Spain. Electronic address: aalvarezy@salud.madrid.org.
  • Servicio de Farmacia Hospitalaria, Hospital Universitario de la Princesa, Madrid, Spain.
  • Servicio de Oncología Médica, Hospital Universitario de la Princesa, Madrid, Spain.
  • Departamento de Farmacología, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain.

Zitieren

APA

Álvarez-Yuste, A., Pérez-Abánades, M., Colomer-Bosch, R., Cuadrado-Berrocal, I., Rogado-Revuelta, J., Gallego-Aranda, T., & Aranguren-Oyarzábal, A. (2026). [Translated article] Cost-effectiveness of immune checkpoint inhibitors for non-small cell lung cancer in a third level hospital. Farmacia Hospitalaria. https://doi.org/10.1016/j.farma.2026.04.017

Vancouver

Álvarez-Yuste A, Pérez-Abánades M, Colomer-Bosch R, Cuadrado-Berrocal I, Rogado-Revuelta J, Gallego-Aranda T, et al. [Translated article] Cost-effectiveness of immune checkpoint inhibitors for non-small cell lung cancer in a third level hospital. Farmacia Hospitalaria. 2026. doi:10.1016/j.farma.2026.04.017

BibTeX
@article{lvarezYuste2026,
  author = {Álvarez-Yuste, Ana and Pérez-Abánades, María and Colomer-Bosch, Ramón and Cuadrado-Berrocal, Irene and Rogado-Revuelta, Jacobo and Gallego-Aranda, Tomás and Aranguren-Oyarzábal, Ainhoa},
  title = {[Translated article] Cost-effectiveness of immune checkpoint inhibitors for non-small cell lung cancer in a third level hospital},
  journal = {Farmacia Hospitalaria},
  year = {2026},
  doi = {10.1016/j.farma.2026.04.017}
}
Kostenlos starten →